Division of Transplant Anesthesiology, Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA.
Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA.
J Cardiothorac Vasc Anesth. 2019 Oct;33(10):2728-2734. doi: 10.1053/j.jvca.2019.03.011. Epub 2019 Mar 15.
To analyze preoperative tumor thrombus progression and occurrence of perioperative pulmonary embolism (PE) in patients with inferior vena cava tumor thrombus resection.
Retrospective analysis.
University of Washington Medical Center.
Patients who had undergone inferior vena cava tumor resection with thrombectomy from 2014 to 2017.
Analysis of demographic, perioperative, and outcome data. Variables were compared between groups according to the level of tumor thrombus, the timing of the preoperative imaging, and the occurrence of perioperative PE.
Incidence, outcomes, and variables associated with perioperative PE and sensitivity/specificity analyses for optimized preoperative imaging timing, broken into 7-day increments, were assessed. Fifty-six patients were included in this analysis. Perioperative PE was observed in 6 (11%) patients, intraoperatively in 5 patients and in the early postoperative period in 1 patient. Of the 5 patients with intraoperative PE, 2 died intraoperatively. Perioperative PE occurred in 1 patient with tumor thrombus level I, in 2 patients with level II, in 2 patients with level III, and in 1 patient with level IV. Risks of preoperative tumor thrombus progression were minimized if the imaging study was performed within 3 weeks for level I and II tumor thrombi and within 1 week for level III tumor thrombus.
Perioperative PE was observed in patients with all levels of tumor thrombus. Fifty percent of perioperative PE were observed in patients with infrahepatic tumor thrombus. Post-imaging progression of tumor thrombus was unlikely if the surgery was performed within 3 weeks in patients with levels I or II tumor thrombus or within 1 week in patients with level III tumor thrombus.
分析下腔静脉肿瘤血栓切除术患者术前肿瘤血栓进展和围手术期肺栓塞(PE)的发生情况。
回顾性分析。
华盛顿大学医学中心。
2014 年至 2017 年间接受下腔静脉肿瘤切除术和血栓切除术的患者。
分析人口统计学、围手术期和结果数据。根据肿瘤血栓水平、术前影像学检查时间和围手术期 PE 的发生情况,对组间变量进行比较。
评估了发生率、结局以及与围手术期 PE 相关的变量,并对术前影像学检查时间进行了优化,分为 7 天增量,进行了敏感性/特异性分析。本分析共纳入 56 例患者。6 例(11%)患者发生围手术期 PE,5 例术中发生,1 例术后早期发生。5 例术中发生 PE 的患者中,2 例术中死亡。1 例肿瘤血栓水平 I 的患者、2 例肿瘤血栓水平 II 的患者、2 例肿瘤血栓水平 III 的患者和 1 例肿瘤血栓水平 IV 的患者发生围手术期 PE。如果 I 级和 II 级肿瘤血栓的影像学检查在 3 周内进行,III 级肿瘤血栓的影像学检查在 1 周内进行,则术前肿瘤血栓进展的风险最小化。
所有肿瘤血栓水平的患者均发生围手术期 PE。50%的围手术期 PE 发生在肝下肿瘤血栓患者中。如果 I 级或 II 级肿瘤血栓患者在 3 周内或 III 级肿瘤血栓患者在 1 周内进行手术,则肿瘤血栓影像学检查后进展的可能性不大。